Asthma + Lung UK says more needs to be done to prevent the overuse of inhalers.
A major pharmaceutical company ended price hikes and monopoly protection over a life-saving asthma inhaler following two years of pressure from U.S. Sen. Maggie Hassan, D-N.H. Without warning in ...
A major pharmaceutical company ended price hikes and monopoly protection over a life-saving asthma inhaler following two years of pressure from U.S. Sen. Maggie Hassan, D-N.H. Without warning in ...
In 2024, doctors and parents scrambled to find an affordable asthma inhaler after drugmaker GSK pulled the popular Flovent off the market. A senator launched an investigation to find out what happened ...
BOSTON – Families have been left scrambling in recent months after a lifesaving asthma inhaler was taken off the market at the beginning of the year. Flovent HFA and Flovent Diskus, treatments that ...
Concerns over health care’s carbon footprint typically revolve around issues like overly-air-conditioned hospitals and single-use medical supply waste. But researchers like Stanford University’s ...
FABRICE COFFRINI/AFP via Getty Images / AFP Three years after raising health groups’ suspicions by acquiring Vectura, a British pharmaceutical firm that makes asthma inhalers, cigarette giant Philip ...
Dr. Miguel Divo, a lung specialist at Brigham and Women’s Hospital, sits in an exam room, across from one of his patients with asthma. Joel Rubinstein, a retired psychiatrist, is about to get a ...
The news followed an investigation by POLITICO’s E&E News into climate-friendly inhalers and how drug giants are developing them to undermine competition. The pharmaceutical giant AstraZeneca has ...
The people who are most vulnerable to the hard-to-breathe air that comes with climate change may inadvertently be adding to the problem, new research finds. About 34 million Americans have a chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results